AI assistant
Sending…
LEMAITRE VASCULAR INC — Director's Dealing 2015
Nov 20, 2015
31708_dirs_2015-11-20_a9a4ab88-651f-4e3f-852f-7575029ced0a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2015-11-18
Reporting Person: Gebauer Peter R (President, International OP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-18 | Common Stock | M | 100 | $0.102 | Acquired | 70520 | Direct |
| 2015-11-18 | Common Stock | S | 100 | $14.37 | Disposed | 70420 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-18 | Stock Option (Right to Buy) | $0.102 | M | 100 | Disposed | 2007-06-02 | Common Stock (100) | Direct |
Footnotes
F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2: This option is fully vested and exercisable.
F3: This stock option was originally reported on Form 3 as having an expiration date of June 2, 2007, but does not in fact have an expiration date. Because an expiration date is required to be reported, the originally reported expiration date is included for the sake of consistency.
More from LEMAITRE VASCULAR INC
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Apr 14
Annual Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3